Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
September 30th, 2014
Competition in Streptococcus pneumoniae is mediated by bacteriocins, small antimicrobial peptides with inhibitory activity towards pneumococcus and other related species. Here we describe an optimized bacterial overlay assay that allows for the characterization of bacteriocin activity and inhibitory spectrum, bacteriocin-specific immunity, and detection of secreted quorum sensing peptides.
The overall goal of this procedure is to visualize the bacteria and activity of streptococcus pneumonia using the overlay assay. This is accomplished by first stabbing the producer strain onto A TSA plate. In the second step, the overlay strain mixture is prepared and then pipetted slowly onto the TSA plate containing the stepped producer strain.
In the final step, bacterial activity is assessed. Ultimately, the overlay assay can be used to show bacteria inactivity or pheromone production by the stabbed strain of interest. The main advantage of this technique over existing methods like the direct purification of Bacterin, is that this method is a rapid way to establish a range of bacteria, inactivity, and to screen multiple strains for bacteria in production.
Demonstrating the procedure will be Natalie Marchek, a graduate student in my laboratory To prepare the bacteria in producer begin by streak the pneumococcal strain of interest on a 5%sheep blood TSA plate, and incubate the plate overnight at 37 degrees Celsius in 5%carbon dioxide. The next morning pipette 3000 to 4, 000 units of catalysts onto plates containing 25 milliliters of TSA, and use sterile glass beads to spread the catalysts across the plates. After letting the plates dry for about 10 minutes under a biological safety cabinet, collect a visible quantity of bacteria onto a pipette tip and stab the pipette tip into the dried TSA plate.
If possible, include a known bacteria sin producer as a positive control and the strain to be used in the overlay as a negative control, providing adequate space between the stabs so the growth halos will not overlap. Then incubate the stab cultures at 37 degrees Celsius with 5%carbon dioxide for six hours the day before the overlay assay inoculate five to 10 colonies of the pneumococcal strain to be tested in glass tubes containing five milliliters of THY medium containing 0.5%yeast extract. Then close the lids of these glycerol strain cultures and incubate them in a 37 degree Celsius water bath without shaking.
After four to five hours, gently invert the tubes a few times and then measure the od. When the cultures have reached an OD two 60 of 0.3 to 0.5, add glycerol to a final concentration of 20%then aliquot the cultures into 1.5 milliliter micro centrifuge tubes, and store the tubes at minus 80 degrees Celsius. The next morning thaw an aliquot of glycerol stock at room temperature.
Then just prior to the overlay application, mix five milliliters of THY 3000 to 4, 000 units of catalyst and 200 microliters of the glycerol stock in a 15 milliliter conical tube. For reporter bacterial strains add 50 microliters of Xcel to the overlay mixture using one conical tube per plate. Place the overlay mixture at room temperature while the mixture is e equilibrating melt solid TSA in a microwave, and then place it in a 55 degrees Celsius water bath.
When the melted TSA has cooled to 55 degrees Celsius quickly add three milliliters of the TSA to the overlay mixture and pipette up and down several times with a five milliliter pipette. Taking care not to introduce bubbles, then slowly pipette the overlay mixture directly onto the stabbed TSA plate. After a few minutes when the plate has hardened and without rotating the plate, carefully place the overlaid stab culture back into the incubator for overnight culture.
The next morning observe the overnight growth. The plates should appear opaque from the growth of the overlay strain, except in the areas where inhibition or pheromone signaling has occurred. There are two possible outcomes for the overlay assay in this representative experiment.
After overnight culture, a zone of clearance was observed surrounding the stabbed strain, indicating that this overlay strain is sensitive to the bacteria sins being produced. Note also the swirling of the stabbed strain into the overlay mixture. In this experiment, the overlay strain was immune to the bacterin being secreted as indicated by the absence of a halo surrounding the stab.
It is also possible that the stabbed strain does not secrete bacterin for the signaling assay. Two different outcomes are possible. In this experiment, the stabbed strain secreted a pheromone that interacted with the histidine kinase of the overlay strain as observed by the blue zone indicating the breakdown of xal in this image.
If the pheromone does not activate the transcription of the BLP locus in the reporter's strain, or if the stabbed strain does not secrete a pheromone, the breakdown of X scale will not occur as observed in this image Following this procedure. Other methods like mutational analysis or sequencing can be performed to answer additional questions like whether any appreciable inhibitory activity is attributable to the BLP locus or is a lack of activity as a result of a mutation in the transporter gene.
View the full transcript and gain access to thousands of scientific videos
Overview
This article describes an optimized bacterial overlay assay to visualize the activity of Streptococcus pneumoniae. The assay allows for the characterization of bacteriocin activity, immunity, and detection of quorum sensing peptides.
Key Study Components
Area of Science
- Microbiology
- Antimicrobial peptides
- Bacterial competition
Background
- Streptococcus pneumoniae competes using bacteriocins.
- Bacteriocins are small antimicrobial peptides.
- Understanding bacteriocin activity can inform treatment strategies.
- Quorum sensing plays a role in bacterial communication.
Purpose of Study
- To visualize bacterial activity using an overlay assay.
- To assess bacteriocin activity and inhibitory spectrum.
- To detect quorum sensing peptides.
Methods Used
- Stabbing the producer strain onto a TSA plate.
- Preparing and applying the overlay strain mixture.
- Assessing bacterial activity post-overlay.
- Comparing this method to direct purification techniques.
Main Results
- The overlay assay effectively shows bacterial inactivity.
- It allows for screening multiple strains quickly.
- Demonstrates pheromone production by the producer strain.
- Provides a rapid alternative to existing methods.
Conclusions
- The optimized overlay assay is a valuable tool for studying bacteriocins.
- This method enhances understanding of bacterial interactions.
- It can facilitate further research into antimicrobial strategies.
Frequently Asked Questions
Executive Industry Relevance
The overlay assay enables rapid screening of bacterial strains for bacteriocin production and sensitivity, supporting early-stage target validation in antimicrobial discovery. By visualizing competitive interactions and quorum sensing signaling, the method provides mechanistic insights into bacterial competition that can inform lead identification and de-risking of antimicrobial candidates. This approach aids in prioritizing strains or pathways with therapeutic potential before investing in resource-intensive purification or characterization efforts.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by linking bacteriocin production to competitive fitness in polymicrobial environments.
- Operational Value: Enables functional validation of the blp locus as a determinant of bacterial antagonism without requiring peptide purification.
- Predictive Value: Supports portfolio triage by identifying strains with active bacteriocin secretion for further mechanistic de-risking.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream antimicrobial screening by confirming bacteriocin activity and immunity profiles.
- Operational Value: Standardizes qualitative readouts (zones of clearance, pheromone-induced reporter signals) across multiple strains for reproducible comparative analysis.
- Scalability Value: Facilitates high-throughput assessment of strain libraries, enabling rapid identification of producers and sensitive indicators for assay optimization.
Translational & Preclinical Research
- Translational Value: Connects discovery-phase bacteriocin activity to preclinical relevance by characterizing strain-specific inhibitory spectra and immune evasion mechanisms.
- Mechanistic De-risking: Clarifies whether observed inhibition is attributable to the blp locus, reducing false positives in antimicrobial hit validation.
- Biomarker Alignment: Detects secreted quorum sensing peptides that may serve as translational biomarkers for pathway activation in native environments.
Pipeline & Workflow Integration
The overlay assay fits within the early discovery continuum, supporting hypothesis testing in target validation and enabling assay readiness for lead identification workflows focused on antimicrobial peptides.
- Discovery Biology: Tests hypotheses about bacterial competition mechanisms by visualizing bacteriocin-mediated inhibition and strain-specific sensitivity patterns.
- Screening: Generates qualitative activity readouts that inform assay standardization and reproducibility for screening campaigns targeting bacteriocin producers.
- Analytics: Provides measurable outputs such as inhibition zone formation and reporter gene activation (e.g., lacZ breakdown) to compare conditions and track pathway modulation.
- Translational Research: Links laboratory observations of bacteriocin secretion to potential in vivo relevance by assessing functionality of the blp locus in clinical or environmental isolates.
- Enterprise Reuse: Establishes a reusable screening platform for evaluating bacteriocin activity across diverse strain panels, reducing redundant method development.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing mechanistic ambiguity around bacteriocin-mediated competition.
- Operational Value: Enhances reproducibility and standardization of qualitative antimicrobial activity assessments across laboratories.
- Strategic Value: Improves go/no-go decisions in early antimicrobial programs by rapidly identifying false-negative producers or immune strains.
- Portfolio Impact: Enables risk-adjusted prioritization of strains or loci based on demonstrated bacteriocin functionality and sensitivity profiles.
Implementation Considerations
- Requires expertise in anaerobic bacterial handling and sterile overlay techniques to prevent contamination and ensure accurate zone interpretation.
- Dependent on access to TSA plates, THY medium, lacZ-reporter strains, and controlled incubation environments (37°C, 5% CO2).
- Necessitates standardization of stab depth, overlay volume, and incubation times to ensure reproducible inhibition or signaling readouts across users.
- Must account for variability in strain growth kinetics and pheromone secretion timing when adapting the assay to new genetic backgrounds or species.
- Limited to qualitative or semi-quantitative outputs; complementary methods (e.g., mutagenesis, sequencing) are needed to confirm blp locus dependence or transporter functionality.
